Literature DB >> 26110205

Diffusion-weighted MRI in the follow-up of chronic periaortitis.

L Kamper1, P Haage1, A S Brandt2, W Piroth1, N Abanador-Kamper3, S Roth2, H Ekamp1.   

Abstract

OBJECTIVE: To evaluate the usefulness of diffusion-weighted MRI (DWI) for the assessment of the intraindividual follow-up in patients with chronic periaortitis (CP) under medication.
METHODS: MRI data of 21 consecutive patients with newly diagnosed untreated disease were retrospectively examined before and after medical therapy, with a median follow-up of 16 weeks. DWI parameters [b800 signal, apparent diffusion coefficient (ADC) values] of the CP and psoas muscle were analysed together with the extent and contrast enhancement. Pre- and post-treatment laboratory inflammation markers were acquired parallel to each MR examination.
RESULTS: Statistically significant lower b800 signal intensities (p ≤ 0.0001) and higher ADC values (p ≤ 0.0001) were observed after medical treatment within the fibrous periaortic tissue. Extent and contrast enhancement of the CP showed also a statistically significant decrease (p ≤ 0.0001) in the follow-up examinations, while the control parameters within the psoas muscle showed no differences.
CONCLUSION: DWI seems to be a useful method for the evaluation of response to treatment without contrast agents. The technique may be helpful in the assessment of disease activity to guide further therapeutic strategies. ADVANCES IN KNOWLEDGE: DWI detects significant differences in the intraindividual follow-up of CP under medical therapy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26110205      PMCID: PMC4651399          DOI: 10.1259/bjr.20150145

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  29 in total

Review 1.  The spectrum of chronic periaortitis.

Authors:  D V Parums
Journal:  Histopathology       Date:  1990-05       Impact factor: 5.087

2.  Diffusion-weighted MRI findings of treated and untreated retroperitoneal fibrosis.

Authors:  Lars Kamper; Alexander Sascha Brandt; Hendrik Ekamp; Nadine Abanador-Kamper; Werner Piroth; Stephan Roth; Patrick Haage
Journal:  Diagn Interv Radiol       Date:  2014-11       Impact factor: 2.630

Review 3.  [Chronic periaortitis].

Authors:  J H Schirmer; M Both; F Moosig
Journal:  Internist (Berl)       Date:  2013-12       Impact factor: 0.743

Review 4.  Ormond's disease or secondary retroperitoneal fibrosis? An overview of retroperitoneal fibrosis.

Authors:  M Heckmann; M Uder; M A Kuefner; M C Heinrich
Journal:  Rofo       Date:  2009-03-16

5.  Long-term safety and efficacy of a tamoxifen-based treatment strategy for idiopathic retroperitoneal fibrosis.

Authors:  E F H van Bommel; L G Pelkmans; H van Damme; T R Hendriksz
Journal:  Eur J Intern Med       Date:  2012-12-13       Impact factor: 4.487

6.  Role of gadolinium-enhanced magnetic resonance imaging in retroperitoneal fibrosis.

Authors:  Paul R Burn; Sadmeet Singh; Syed Barbar; Gregory Boustead; Chris M King
Journal:  Can Assoc Radiol J       Date:  2002-06       Impact factor: 2.248

7.  Usefulness of the calculated apparent diffusion coefficient value in the differential diagnosis of retroperitoneal masses.

Authors:  Tomohiro Nakayama; Kengo Yoshimitsu; Hiroyuki Irie; Hitoshi Aibe; Tsuyoshi Tajima; Kenji Shinozaki; Akihiro Nishie; Yoshiki Asayama; Daisuke Kakihara; Shuji Matsuura; Hiroshi Honda
Journal:  J Magn Reson Imaging       Date:  2004-10       Impact factor: 4.813

Review 8.  Application of extracellular gadolinium-based MRI contrast agents and the risk of nephrogenic systemic fibrosis.

Authors:  J T Heverhagen; G A Krombach; E Gizewski
Journal:  Rofo       Date:  2014-01-29

9.  Role of diffusion-weighted MR imaging in the differentiation of benign retroperitoneal fibrosis from malignant neoplasm: preliminary study.

Authors:  Baris Bakir; Fatma Yilmaz; Rustu Turkay; Sevda Ozel; Bilge Bilgiç; Arzu Velioglu; Bulent Saka; Artur Salmaslioglu
Journal:  Radiology       Date:  2014-04-01       Impact factor: 11.105

10.  Tamoxifen monotherapy in the treatment of retroperitoneal fibrosis.

Authors:  Alexander Sascha Brandt; Lars Kamper; Sonja Kukuk; Patrick Haage; Stephan Roth
Journal:  Urol Int       Date:  2014-07-26       Impact factor: 2.089

View more
  5 in total

Review 1.  [Diseases of connective tissue in IgG4-associated autoimmune diseases].

Authors:  G A Krombach
Journal:  Radiologe       Date:  2016-12       Impact factor: 0.635

2.  Diffusion-weighted MR in chronic periaortitis, a new technique has entered the clinical arena.

Authors:  Kevin Kalisz; Sasan Partovi
Journal:  Int J Cardiovasc Imaging       Date:  2018-09-29       Impact factor: 2.357

3.  Diffusion-weighted MRI and PET-CT in the follow up of chronic periaortitis.

Authors:  L Kamper; N M Dreger; A S Brandt; T Pöppel; N Abanador-Kamper; S Roth; P Haage
Journal:  Int J Cardiovasc Imaging       Date:  2018-06-15       Impact factor: 2.357

Review 4.  [New (and old) aspects of retroperitoneal fibrosis].

Authors:  A S Brandt; N M Dreger; E Müller; S Kukuk; S Roth
Journal:  Urologe A       Date:  2017-07       Impact factor: 0.639

5.  A prospective study comparing whole-body skeletal X-ray survey with 18F-FDG-PET/CT, 18F-NaF-PET/CT and whole-body MRI in the detection of bone lesions in multiple myeloma patients.

Authors:  Eva Dyrberg; Helle W Hendel; Gina Al-Farra; Lone Balding; Vibeke B Løgager; Claus Madsen; Henrik S Thomsen
Journal:  Acta Radiol Open       Date:  2017-10-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.